Table 3 Patient baseline characteristics
From: The feasibility of implementing an English language version of GLA:D Back
GLA:D® Back Group (n=74) baseline | |
|---|---|
Sociodemographic | |
Females, n (%) | 49 (66%) |
Age, mean (SD) | 55.5 (13.4) |
Height | 167.6 (10.5) |
Weight | 80.22(17.7) |
No qualification | 0 |
Vocational training | 18 (24%) |
Higher education < 3 years | 32 (44%) |
Higher education > 3 years | 8 (11%) |
Ordinary work, n=69 | 26 (38%) |
Unemployed | 0 (0%) |
Rehabilitation | 0 |
Retired | 20 (29%) |
Student/housewife/other, n=69 | 12 (17%) |
Clinical symptoms | |
Pain duration, n=72 | |
< 4 weeks | 12 (17%) |
4–12 weeks | 4 (6%) |
3–12 months | 13 (18%) |
> 1 year | 43 (60%) |
Previous episodes, n=74 | |
0 | 16 (22%) |
1 | 10 (14%) |
2–3 | 12 (16%) |
> 3 | 36 (49%) |
Time since treatment-initiated, n=71 | |
< 2 weeks | 10 (14%) |
2–4 weeks | 12 (17%) |
> 4 weeks | 49 (69%) |
No. of health care visits for present LBP, n=69 | |
1 | 29 (43%) |
2–5 | 32 (47%) |
6–10 | 4 (6%) |
> 10 | 3 (4%) |
Pain medication | n=82 |
None | 41 (50%) |
Over the counter | 25 (30.5%) |
Prescription | 14 (19%) |
START Back risk | |
Low | 12 (16%) |
Medium | 29 (39%) |
High | 33 (45%) |
Sick leave last 3 months* (n=45) | |
0 days | 28 (62%) |
1–14 days | 12 (29%) |
> 15 days | 4 (9%) |
EQ-5D 0-100(SD) | 68.9 (18.0) |